The Excellence in Pediatrics Spot The Early Signs program aims to fight under-diagnosed or late-diagnosed conditions for which treatments are available and where early detection and early treatment could make a significant difference in the condition's development, the quality of life and the survival of patients.
Alpha-mannosidosis (AM) is an ultra-rare genetic disorder caused by a deficiency of the lysosomal enzyme alpha-mannosidase. The symptoms, severity, and progression of alpha-mannosidosis vary widely between individuals, making diagnosis challenging and often delayed. Minimizing the time to diagnosis is important in ensuring that individuals with alpha-mannosidosis and their families receive timely access to support and specialist MDT care.
To assist, EIP has launched the Spot the Early Signs of AM Resource Centre to spread education among frontline pediatricians and general practitioners, helping them understand the disease and recognise the symptoms when they examine patients. The Resource Centre offers a platform for members to collaborate, engage, and interact, providing easy access to information and educational resources when needed. This facility is available for members themselves and for sharing with colleagues. All recorded webinars are free to view via the Recorded Webinars Section, along with further information on the Faculty, the Upcoming Live New Webinars and how you can Join Us to motivate your colleagues to ‘Think Rare’ in every consultation.
Join the Spot the Early Sign Program Network and help mobilise child healthcare professionals' collective power to ’think rare’ and look for the signs of rare diseases in every consultation. As a network member, you can volunteer as the primary contact point in your clinic, hospital or institution and disseminate the Spot the Early Signs material and resources to your colleagues. You can also volunteer to deliver a Spot the Early Signs Webinar in a local language with all slides and material provided by EIP. Signing up and accessing all the latest guidance, webinars, and educational materials is free.
Alpha-mannosidosis: Minimising Delays in Diagnosis and Referral of PatientsThe symptoms, severity, and progression of AM vary widely between individuals, making diagnosis challenging and often delayed. Minimising the time to diagnosis is important in ensuring that individuals with AM and their families receive timely access to support and specialist MDT care. |
||
Metachromatic Leukodystrophy:
|
||
Mucopolysaccharidosis: Understanding the path to successful diagnosis of MPS in childrenMisdiagnosis of MPS often leads to delayed diagnosis, as symptoms are commonly mistaken for other conditions. This frequently results in attempts to treat symptoms directly, thus postponing the actual diagnosis and treatment or referring the patient to incorrect pediatric specialties. Explore our MPS resource centre to discover 38 free webinars. These sessions are tailored to enhance your understanding of the disease and guide you through the referral and diagnosis process. |
|